Strategic partnerships MTI has recently announced collaboration with MERIT CRO and Bridgeworx to accelerate commercialization of respiratory management solutions and establish standardized spirometry endpoints, signaling a receptive market for integrated data platforms and remote respiratory monitoring services.

Home and clinic expansion The company focuses on making lung function testing accessible across clinic and home settings, presenting sales opportunities for remote patient monitoring devices, home spirometry solutions, and accompanying software to health systems and CROs expanding at-home clinical trials.

Growth and scale With revenue in the low to mid range and a funding cushion of almost ten million dollars, MTI is positioned to invest in sales and deployment of respiratory data platforms to mid-market health systems, OEMs, and contract research organizations seeking standardized endpoints.

Leadership signal New board leadership including prominent executives from healthcare distribution and life sciences indicates strategic openness to partnerships, channel sales, and enterprise deals with pharma sponsors and CROs seeking integrated measurement solutions.

Tech-enabled value MTI combines devices, software intelligence, and guided workflows on a unified platform, creating upsell and cross-sell opportunities for bundled solutions, data analytics services, and compliance-ready respiratory data management for clinical trials and routine care.